Brief: Oncocyte Reports Preliminary Fourth Quarter Results
31/03/2023 22:34
March 31 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PLANS TO FILE FORM 12B-25 TO EXTEND FILING
DATE OF ITS FORM 10-K
Source text for Eikon: ID:nGNX2V6Hy6
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission